Raschi E, Fusaroli M, Ardizzoni A, Poluzzi E, et al. Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment. Breast Cancer Res Treat 2021;186:219-227.
PMID: 33150548